Total Clarity Wealth Management Inc. Has $392,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Total Clarity Wealth Management Inc. decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 751 shares of the medical equipment provider’s stock after selling 38 shares during the period. Total Clarity Wealth Management Inc.’s holdings in Intuitive Surgical were worth $392,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Brighton Jones LLC boosted its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Union Bancaire Privee UBP SA bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $6,509,000. Bank of Stockton boosted its position in shares of Intuitive Surgical by 13.5% during the 4th quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider’s stock valued at $606,000 after purchasing an additional 138 shares in the last quarter. Vontobel Holding Ltd. boosted its position in shares of Intuitive Surgical by 5.8% during the 4th quarter. Vontobel Holding Ltd. now owns 48,776 shares of the medical equipment provider’s stock valued at $25,459,000 after purchasing an additional 2,655 shares in the last quarter. Finally, First Merchants Corp bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $201,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.2%

ISRG stock opened at $512.18 on Friday. Intuitive Surgical, Inc. has a twelve month low of $413.82 and a twelve month high of $616.00. The stock’s 50 day moving average is $526.57 and its 200-day moving average is $538.46. The firm has a market capitalization of $183.57 billion, a PE ratio of 79.90, a P/E/G ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter last year, the company earned $1.50 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research analyst reports. Robert W. Baird cut their target price on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Citigroup reiterated a “buy” rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday, June 5th. Truist Financial cut their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a “hold” rating to a “sell” rating and cut their price target for the stock from $515.00 to $440.00 in a report on Monday, June 9th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $588.95.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president now directly owns 907 shares of the company’s stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Gary Loeb sold 1,700 shares of the stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president now directly owns 2,245 shares of the company’s stock, valued at $1,152,089.10. The trade was a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.